Vida Ventures named Matt Cohen and Brian Goodman new Managing Directors today. BiotechTV caught up with Brian in Vida's Boston office

Brian Goodman, Managing Director at Vida Ventures, shares insights from his extensive background in life sciences investing at MPM Bio Impact Fund. He discusses current trends in early-stage biotech investments, particularly in immunology, oncology, and neurology. The resilience of the sector amidst economic uncertainties is highlighted, along with the challenges and opportunities for innovation. Goodman also elaborates on Vida's strategies for supporting portfolio companies while seeking new investments, particularly within Boston's dynamic biotech landscape.